Champions Oncology, Inc. (CSBR)
NASDAQ: CSBR · Real-Time Price · USD
7.51
-0.05 (-0.60%)
At close: Dec 20, 2024, 4:00 PM
7.15
-0.35 (-4.73%)
After-hours: Dec 20, 2024, 4:07 PM EST
Champions Oncology Revenue
Champions Oncology had revenue of $13.49M in the quarter ending October 31, 2024, with 16.56% growth. This brings the company's revenue in the last twelve months to $53.57M, up 7.19% year-over-year. In the fiscal year ending April 30, 2024, Champions Oncology had annual revenue of $50.16M, down -6.90%.
Revenue (ttm)
$53.57M
Revenue Growth
+7.19%
P/S Ratio
1.90
Revenue / Employee
$255,100
Employees
210
Market Cap
102.81M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Apr 30, 2024 | 50.16M | -3.72M | -6.90% |
Apr 30, 2023 | 53.87M | 4.76M | 9.69% |
Apr 30, 2022 | 49.11M | 8.07M | 19.66% |
Apr 30, 2021 | 41.04M | 8.92M | 27.76% |
Apr 30, 2020 | 32.12M | 5.06M | 18.68% |
Apr 30, 2019 | Pro | Pro | Pro |
Apr 30, 2018 | Pro | Pro | Pro |
Apr 30, 2017 | Pro | Pro | Pro |
Apr 30, 2016 | Pro | Pro | Pro |
Apr 30, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionCSBR News
- 10 days ago - Champions Oncology, Inc. (CSBR) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 10 days ago - Champions Oncology Reports Quarterly Revenue of $13.5 Million Adjusted EBITDA of $1.1 Million - Accesswire
- 16 days ago - Champions Oncology to Announce Second Quarter Financial Results on Wednesday, December 11, 2024 - Accesswire
- 2 months ago - Champions Oncology Announces Agreement with Weill Cornell Medicine - Accesswire
- 3 months ago - Champions Oncology, Inc. (CSBR) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Champions Oncology Reports Quarterly Revenue of $14.1 Million Adjusted EBITDA of $2.0 Million - Accesswire
- 3 months ago - Champions Oncology to Announce First Quarter Financial Results on Wednesday, September 11, 2024 - Accesswire
- 5 months ago - Champions Oncology, Inc. (CSBR) Q4 2024 Earnings Call Transcript - Seeking Alpha